| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Baird Medical Investment Holdings Ltd
13D
BDMD · G0705H103
|
19.1% |
7/31/2026
Event 10/1/2024
|
||||
| ExcelFin SPAC LLC | 11.6% | |||||
| Grand Fortune Capital (HK) Co Ltd | 19.1% | |||||
| Grand Fortune Capital, LLC | 0.8% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.